Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results67% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (7)
P 4 (3)

Trial Status

Completed4
Recruiting4
Terminated2
Withdrawn1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (11)

Research Network

Activity Timeline